For: | Lu YS, Lien HC, Yeh PY, Yeh KH, Kuo ML, Kuo SH, Cheng AL. Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. World J Gastroenterol 2005; 11(40): 6373-6380 [PMID: 16419168 DOI: 10.3748/wjg.v11.i40.6373] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i40/6373.htm |
Number | Citing Articles |
1 |
Vathany Kulasingam, Eleftherios P. Diamandis. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines. bchm 2007; 388(10): 1113 doi: 10.1515/BC.2007.103
|
2 |
Ronit Vogt Sionov, Rachel Spokoini, Shlomit Kfir‐Erenfeld, Orly Cohen, Eitan Yefenof. . Advances in Cancer Research 2008; 101: 127 doi: 10.1016/S0065-230X(08)00406-5
|
3 |
Chae Hyeong Lee, Yong‐Tark Jeon, Su‐Hyeong Kim, Yong‐Sang Song. NF‐κB as a potential molecular target for cancer therapy. BioFactors 2007; 29(1): 19 doi: 10.1002/biof.5520290103
|
4 |
Ingrid Herr, Markus W. Büchler, Jürgen Mattern. Death Receptors and Cognate Ligands in Cancer. Results and Problems in Cell Differentiation 2009; 49: 191 doi: 10.1007/400_2008_20
|
5 |
Pascale S. Guiton, Thomas J. Hannan, Bradley Ford, Michael G. Caparon, Scott J. Hultgren, R. P. Morrison. Enterococcus faecalis Overcomes Foreign Body-Mediated Inflammation To Establish Urinary Tract Infections. Infection and Immunity 2013; 81(1): 329 doi: 10.1128/IAI.00856-12
|
6 |
Yen-Shen Lu, Huan-Chun Lien, Pei-Yen Yeh, Sung-Hsin Kuo, Wen-Ching Chang, Min-Liang Kuo, Ann-Lii Cheng. Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. Lung Cancer 2006; 53(3): 303 doi: 10.1016/j.lungcan.2006.05.005
|
7 |
E. Kassi, T. G. Sourlingas, M. Spiliotaki, Z. Papoutsi, H. Pratsinis, N. Aligiannis, P. Moutsatsou. Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells. Cancer Investigation 2009; 27(7): 723 doi: 10.1080/07357900802672712
|
8 |
Janet P. Hapgood, Chanel Avenant, Johnson M. Moliki. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy. Pharmacology & Therapeutics 2016; 165: 93 doi: 10.1016/j.pharmthera.2016.06.002
|
9 |
Yian Wang, Weidong Wen, Yijun Yi, Zhongqiu Zhang, Ronald A. Lubet, Ming You. Preventive Effects of Bexarotene and Budesonide in a Genetically Engineered Mouse Model of Small Cell Lung Cancer. Cancer Prevention Research 2009; 2(12): 1059 doi: 10.1158/1940-6207.CAPR-09-0221
|
10 |
Myriam Vilasco, Laudine Communal, Najat Mourra, Aurélie Courtin, Patricia Forgez, Anne Gompel. Glucocorticoid receptor and breast cancer. Breast Cancer Research and Treatment 2011; 130(1): 1 doi: 10.1007/s10549-011-1689-6
|
11 |
Steven Robertson, Janet P. Hapgood, Ann Louw. Glucocorticoid receptor concentration and the ability to dimerize influence nuclear translocation and distribution. Steroids 2013; 78(2): 182 doi: 10.1016/j.steroids.2012.10.016
|
12 |
Steven Robertson, Johann M. Rohwer, Janet P. Hapgood, Ann Louw, Alice Y.W. Chang. Impact of Glucocorticoid Receptor Density on Ligand-Independent Dimerization, Cooperative Ligand-Binding and Basal Priming of Transactivation: A Cell Culture Model. PLoS ONE 2013; 8(5): e64831 doi: 10.1371/journal.pone.0064831
|
13 |
Xian-Guo Meng, Shou-Wei Yue. Dexamethasone Disrupts Cytoskeleton Organization and Migration of T47D Human Breast Cancer Cells by Modulating the AKT/mTOR/RhoA Pathway. Asian Pacific Journal of Cancer Prevention 2015; 15(23): 10245 doi: 10.7314/APJCP.2014.15.23.10245
|
14 |
Kerryn M Taylor, David W Ray, Paula Sommer. Glucocorticoid receptors in lung cancer: new perspectives. Journal of Endocrinology 2016; 229(1): R17 doi: 10.1530/JOE-15-0496
|
15 |
P Sommer, P Le Rouzic, H Gillingham, A Berry, M Kayahara, T Huynh, A White, D W Ray. Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells. Oncogene 2007; 26(50): 7111 doi: 10.1038/sj.onc.1210524
|
16 |
Adrian C Jaramillo, Andries M Bergman, Elizabeth M Comijn, Gerrit Jansen, Gertjan J L Kaspers, Jacqueline Cloos, Godefridus J Peters. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase. Nucleosides, Nucleotides & Nucleic Acids 2020; 39(10-12): 1346 doi: 10.1080/15257770.2020.1780441
|
17 |
Henriett Butz, Attila Patócs. Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. Cancer and Metastasis Reviews 2022; 41(4): 803 doi: 10.1007/s10555-022-10047-1
|
18 |
Junjia Zhang, Yasuhiro Miki, Erina Iwabuchi, Junyao Xu, Ayako Kanai, Yasuaki Sagara, Yasuyo Ohi, Yoshiaki Rai, Rin Yamaguchi, Maki Tanaka, Takanori Ishida, Takashi Suzuki, Hironobu Sasano. Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients. Breast Cancer Research and Treatment 2023; 200(3): 323 doi: 10.1007/s10549-023-06990-4
|
19 |
Farzaneh Motafeghi, Parham Mortazavi, Nasrin Ghassemi-Barghi, Mohammad Zahedi, Mohammad Shokrzadeh. Dexamethasone as an anti-cancer or hepatotoxic. Toxicology Mechanisms and Methods 2023; 33(2): 161 doi: 10.1080/15376516.2022.2105183
|
20 |
Paraskevi Moutsatsou, Athanasios G. Papavassiliou. The glucocorticoid receptor signalling in breast cancer. Journal of Cellular and Molecular Medicine 2008; 12(1): 145 doi: 10.1111/j.1582-4934.2007.00177.x
|
21 |
Yasmin Ohana Haim, Naamit Deshet Unger, Miriam C. Souroujon, Moshe Mittelman, Drorit Neumann. Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone. Scientific Reports 2014; 4(1) doi: 10.1038/srep04323
|